Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists
Ana-Luisa Silva(University of Cambridge), Ashraf Erian Ibrahim(MRC Laboratory of Molecular Biology), Simon Tavaré(Ludwig Cancer Research), Sarah Dawson(Papworth Hospital NHS Foundation Trust), Mariann Bienz(MRC Laboratory of Molecular Biology), Kiran Guttula(University of Cambridge), Tim H-M. Huang(The University of Sydney), Ewen Cameron(Addenbrooke's Hospital), Mark J. Arends(Edinburgh Cancer Research), Nigel R. Hall(Addenbrooke's Hospital), James D. Brenton(Cambridge University Hospitals NHS Foundation Trust)
Cited by 81
Related Papers
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Driver mutations in <i>TP53</i> are ubiquitous in high grade serous carcinoma of the ovary
|The Journal of Pathology|2010|836
Mutation of <i>FOXL2</i> in Granulosa-Cell Tumors of the Ovary
|New England Journal of Medicine|2009|775